Feedback / Questions
lorigerlimab (MGD019) - MacroGenics
vobramitamab duocarmazine (MGC018) - MacroGenics
https://www.globenewswire.com/news-release/2024/08/06/2925415/0/en/MacroGenics-Provides-Update-on-Corporate-Progress-Second-Quarter-2024-Financial-Results.html
Aug 6, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next